Ameritas Investment Partners’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$87.5K Sell
2,361
-210
-8% -$6.72K ﹤0.01% 1765
2025
Q4
$51.9K Hold
2,571
﹤0.01% 2094
2025
Q3
$77.4K Hold
2,571
﹤0.01% 1845
2025
Q2
$33.2K Hold
2,571
﹤0.01% 2431
2025
Q1
$18.7K Hold
2,571
﹤0.01% 2584
2024
Q4
$42.8K Hold
2,571
﹤0.01% 2278
2024
Q3
$33K Hold
2,571
﹤0.01% 2411
2024
Q2
$28.7K Hold
2,571
﹤0.01% 2446
2024
Q1
$31.9K Hold
2,571
﹤0.01% 2373
2023
Q4
$68.2K Hold
2,571
﹤0.01% 1977
2023
Q3
$117K Buy
2,571
+434
+20% +$20.1K ﹤0.01% 1537
2023
Q2
$88.2K Buy
+2,137
New +$70.1K ﹤0.01% 1688

Other funds holding AEHR

Ameritas Investment Partners's AEHR Position: Q1 2026 in Review

Ameritas Investment Partners reduced its Aehr Test Systems (AEHR) stake by 8.2% in Q1 2026, selling an estimated $6.72K and leaving 2,361 shares worth $87.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1765.

Ameritas Investment Partners first reported a position in AEHR in Q2 2023 and has held it in 12 quarters since. The position peaked at $117K in Q3 2023. 191 funds tracked by Wall St. Rank hold AEHR as of Q1 2026.

  • Ameritas Investment Partners held 2,361 shares of Aehr Test Systems worth $87.5K as of Q1 2026.
  • Ameritas Investment Partners sold 210 Aehr Test Systems shares in Q1 2026, an estimated $6.72K.
  • Aehr Test Systems made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #1765 holding.
  • Ameritas Investment Partners first reported a position in Aehr Test Systems in Q2 2023 and has held it in 12 quarters since.
  • Ameritas Investment Partners's Aehr Test Systems position peaked at $117K in Q3 2023.
  • 191 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.